Developing advanced MRI technology to identify early signs of Alzheimer's disease

ADVANCED COMPREHENSIVE MAGNETIC RESONANCE SOLUTION FOR THE NONINVASIVE CHARACTERIZATION OF HIGH RESOLUTION METABOLIC BIOMARKERS OF RISK IN PATIENTS WITH ALZHEIMER'S DISEASE AND DEMENTIA

NIH-funded research Advanced Imaging Research, INC. · NIH-11130773

This study is testing a new technology that improves brain scans to help find early signs of Alzheimer's disease, so patients can get diagnosed sooner and manage their condition better.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionAdvanced Imaging Research, INC. NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-11130773 on NIH RePORTER

What this research studies

This research focuses on creating a cutting-edge hardware-software system called ADRD360 that enhances magnetic resonance imaging (MRI) and spectroscopy (MRS) to detect metabolic biomarkers associated with Alzheimer's disease and related dementias. By improving the resolution of brain imaging, the project aims to identify early indicators of Alzheimer's risk, which could lead to timely interventions. The approach involves optimizing radio-frequency coils and imaging techniques to achieve unprecedented clarity in brain scans. Patients may benefit from earlier diagnosis and better management of their condition through this innovative technology.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, including those with a family history or early cognitive symptoms.

Not a fit: Patients with advanced Alzheimer's disease or those who do not exhibit any risk factors for the disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could enable earlier detection of Alzheimer's disease, allowing for timely treatment and improved patient outcomes.

How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for early detection of Alzheimer's, suggesting that this approach could build on existing knowledge.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease detection
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.